Uticaj rutinske limfadenektomije hepatičnog sliva na trajanje resekcije jetre zbog metastaza kolorektalnog karcinoma

  • Dragan D Basarić University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • Ivan Soldatović University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • Nebojša S Lekić University of Belgrade, Faculty of Medicine, Belgrade, Serbia
  • Vladimir Djordjević Clinical Centre of Serbia, †First Surgical Clinic, Belgrade, Serbia
  • Ljubomir Djurašić Clinical Centre of Serbia, Clinic for Physical Medicine and Rehabilitation, Serbia
  • Marjan Micev Clinical Centre of Serbia, Department of Pathology, Belgrade, Serbia
Keywords: kolorektalne neoplazme, jetra, neoplazme, limfne metastaze, operativne procedure, lečenje, ishod

Abstract


Apstrakt

 

Uvod/Cilj. Metastaze su u današnje vreme samo relativna kontraindikacija za hirurško lečenje kolorektalnog karcinoma (KRK). Cilj ove studije je bio da se utvrdi uticaj rutinske limfadenektomije hepatičnog sliva na trajanje resekcije jetre zbog metahronih jetrinih metastaza KRK. Metode. Ukupno 50 bolesnika sa metastazama jetre KRK pod­vrgnuto je resekciji jetre sa rutinskom limfadenektomijom hepatičnog sliva. Rezultati. Veći volumen metastaza jetre (u mL), broj zahvaćenih segmenata jetre, broj metastaza u jetri i veličina najveće metastaze u jetri (u mm) određivali su dužinu trajanja resekcije jetre i operacije u celini. Vreme trajanja limfadenektomije iznosilo  je od 25 do 55 min (prosečno 32,2 min). Zaključak. Rutinska limfadenektomija hepa­tičnog sliva kod resekcije jetre zbog metahronih metastaza KRK neznatno produžava vreme trajanja operacije.

References

REFERENCES

August DA, Sugarbaker PH, Schneider PD. Lymphatic dissemina¬tion of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer 1985; 55(7): 1490–4.

Lefor AT, Hughes KS, Shiloni E, Steinberg SM, Vetto JT, Papa MZ, et al. Intra-abdominal extrahepatic disease in patients with co¬lorectal hepatic metastases. Dis Colon Rectum 1988; 31(2): 100–3.

Rosai J. Colon. In: Rosai J, editor. Rosai and Ackerman's Surgi¬cal Pathology.. 9th ed. Philadelphia: Mosby; 2004. p. 776–855.

Kokudo N, Sato T, Seki M, Ohta H, Azekura K, Ueno M, et al. He¬patic lymph node involvement in resected cases of liver metastases from colorectal cancer. Dis Colon Rectum 1999; 42(10): 1285–90; discussion 1290–1.

Elias D, Saric J, Jaeck D, Arnaud JP, Gayet B, Rivoire M, et al. Pro¬spective study of microscopic lymph node involvement of the hepatic pedicle during curative hepatectomy for colorectal metastases. Br J Surg 1996; 83(7): 942–5.

Gurusamy KS, Imber C, Davidson BR. Management of the He-patic Lymph Nodes during Resection of Liver Metastases from Colorectal Cancer. A Systematic Review. HPB Surgery 2008; 2008: 684150.

Scheele J, Stangl R, Altendorf-Hofmann A, Gall FP. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 1991; 110(1): 13–29.

Lupinacci RM, Paye F, Coelho FF, Kruger JA, Herman P. Lym-phatic drainage of the liver and its implications in the man-agement of colorectal cancer liver metastases. Updates Surg 2014; 66(4): 239–45.

Beckurts KT, Hölscher AH, Thorban S, Bollschweiler E, Siewert JR. Significance of lymph node involvement at the hepatic hilum in the resection of colorectal liver metastases. Br J Surg 1997; 84(8): 1081–4.

Jaeck D, Nakano H, Bachellier P, Inoue K, Weber J, Oussoultzoglou E, et al. Significance of hepatic pedicle lymph node involve-ment in patients with colorectal liver metastases: A prospective study. Ann Surg Oncol 2002; 9(5): 430–8.

Elias D, Ouellet JF, Bellon N, Pignon JP, Pocard M, Lasser P. Extra¬hepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 2003; 90(5): 567–74.

Laurent C, Sa Cunha A, Rullier E, Smith D, Rullier A, Saric J. Im¬pact of microscopic hepatic lymph node involvement on sur¬vival after resection of colorectal liver metastasis. J Am Coll Surg 2004; 198(6): 884–91.

Bennett JJ, Schmidt CR, Klimstra DS, Grobmyer SR, Ishill NM, D'An¬gelica M, et al. Perihepatic lymph node micrometastases impact outcome after partial hepatectomy for colorectal me-tastases. Ann Surg Oncol 2008; 15(4): 1130–6.

Nakamura S, Yokoi Y, Suzuki S, Baba S, Muro H. Results of ex-tensive surgery for liver metastases in colorectal carcinoma. Br J Surg 1992; 79(1): 35–8.

Gibbs JF, Weber TK, Rodriguez-Bigas MA, Driscoll DL, Petrelli NJ. Intraoperative determinants of unresectability for patients with colorectal hepatic metastases. Cancer 1998; 82(7): 1244–9.

Moszkowicz D, Cauchy F, Dokmak S, Belghiti J. Routine Pedicular Lymphadenectomy for Colorectal Liver Metastases. J Am Coll Surg 2012; 214(6): 39–44.

Koti RS, Simillis C, Gurusamy KS, Jacovides M, Davidson BR. Man¬agement of the Hepatic Lymph Nodes Durring Resection of Liver Metastases from Colorectal Cancer: A Systematic Re-view. Curr Colorectal Cancer Rep 2013; 9(2): 203–12.

Lupinacci RM, Coelho FF, Kruger J, Perini MV, Herman P. Hilar Lymph Node Involvement in Colorectal Cancer Liver Metas-tases – An Overview. J Gastroint Dig Syst 2011; S6: 002.

Hadden WJ, Reuver PR, Brown K, Mittal A, Samra JS, Hugh TJ. Re¬section of colorectal liver metastases and extra-hepatic dis-ease: A systematic review and proportional meta-analysis of survival outcomes. HPB (Oxford) 2016; 18(3): 209–20.

Suzuki H, Fujii T, Asao T, Tsutsumi S, Wada S, Araki K, et al. Ex¬tracapsular lymph node involvement is associated with co-lorectal liver metastases and impact outcome after hepatec-tomy for colorectal metastases. World J Surg 2014; 38(8): 2079–88.

Nanji S, Tsang ME, Wei X, Booth CM. Regional lymph node in-volvement in patients undergoing liver resection for colorectal cancer metastases. Eur J Surg Oncol 2017; 43(2): 322–9.

Grobmyer SR, Wang L, Gonen M, Fong Y, Klimstra D, Angelica MD, et al. Perihepatic lymph node assessment in patients un-dergoing partial hepatectomy for malignancy. Ann Surg 2006; 244(2): 260–4.

Rau C, Blanc B, Ronot M, Dokmak S, Aussilhou B, Faivre S, et al. Neither preoperative computed tomography nor intra-opera-tive examination can predict metastatic lymph node in the he-patic pedicle in patients with colorectal liver metastasis. Ann Surg Oncol 2012; 19(1): 163–8.

Carpizo DR, D'Angelica M. Liver resection for metastatic colo-rectal cancer in the presence of extrahepatic disease. Ann Surg Oncol. 2009; 16(9): 2411–21.

Ishibashi K, Ishida H, Ohsawa T, Okada N, Kumamoto K, Haga N. Impact of hepatic lymph node metastasis on survival of pa-tients with synchronous resectable or unresectable liver me-tastases of colorectal cancer. Tech Coloproctol 2013; 17(1): 51–7.

Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for me-tastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230(3): 309–18.

Rodgers MS, McCall JL. Surgery for colorectal liver metastases with hepatic lymph node involvement: A systematic review. Br J Surg 2000; 87(9): 1142–55.

Liu W, Yan X, Wang K, Bao Q, Sun Y, Xing B. The outcome of liver resection and lymphadenectomy for hilar lymph node in-volvement in colorectal cancer liver metastases. Int J Colorec-tal Dis 2014; 29(6): 737–45.

Gallinger S, Biagi JJ, Fletcher GG, Nhan C, Ruo L, McLeod RS. Liver resection for colorectal cancer metastases. Curr Oncol 2013; 20(3): e255–65.

Bradatsch A, Kornprat P, Bacher H, Cerwenka H, Haybaeck J, Mi-schinger H. The Value of Lymph Node Dissection in the Sur-gery of Colorectal Cancer Liver Metastases. Anticancer Res 2016; 36(6): 2993–7.

Yuasa N, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M. Angiographic changes in the hepatic artery after skeletoniza-tion resection for biliary tract cancer. Br J Surg 1994; 81(4): 591–4.

Viana EF, Herman P, Siqueira SC, Taka T, Carvalho P, Coelho FF, et al. Lymphadenectomy in colorectal cancer liver metastases resection: Incidence of hilar lymph nodes micrometastasis. J Surg Oncol 2009; 100(7): 534–7.

Ercolani G, Grazi GL, Ravaioli M, Grigioni WF, Cescon M, Gardini A, et al. The role of lymphadenectomy for liver tumors: Fur¬ther considerations on the appropriateness of treatment strat¬egy. Ann Surg 2004; 239(2): 202–9.

Published
2021/02/24
Section
Original Paper